External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer

被引:0
|
作者
Barth, D. A. [1 ]
Riedl, J. M. [1 ]
Foris, V. [2 ]
Posch, F. [1 ]
Mollnar, S. [1 ]
Stotz, M. [1 ]
Pichler, M. [1 ,3 ,4 ]
Stoeger, H. [1 ]
Absenger, G. [1 ]
Olschewski, H. [2 ]
Gerger, A. [1 ,5 ]
机构
[1] Med Univ Graz, Div Clin Oncol, Dept Med, Graz, Austria
[2] Med Univ Graz, Div Pulmonol, Dept Med, Graz, Austria
[3] Med Univ Graz, Res Unit Noncoding RNAs & Genome Editing, Graz, Austria
[4] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[5] Ctr Biomarker Res Med, Graz, Austria
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P403
引用
收藏
页码:108 / 108
页数:1
相关论文
共 50 条
  • [41] Predicting response to immunotherapy in advanced non-small cell lung cancer
    Rebordao Pires, M.
    Amorim Costa, C.
    Cunha Pereira, T.
    Monteiro, J. C.
    Domingues, I.
    Caetano, A. C.
    Meira Garcia, A. R.
    Jesus, E.
    Sousa, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S768 - S768
  • [42] Immunotherapy in treatment naive advanced non-small cell lung cancer
    Ernani, Vinicius
    Ganti, Apar Kishor
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S412 - S421
  • [43] Immunotherapy for Non-Small Cell Lung Cancer
    Yoon, Sung Ho
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (03) : 111 - 115
  • [44] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [45] Immunotherapy in non-small cell lung cancer
    Peters, Geoffrey
    John, Thomas
    CANCER FORUM, 2018, 42 (01) : 24 - 28
  • [46] Immunotherapy for non-small cell lung cancer
    Kagamu, Hiroshi
    RESPIRATORY INVESTIGATION, 2024, 62 (02) : 307 - 312
  • [47] Prognostic Value of Systemic Immune Inflammation Index in Advanced Non Small Cell Lung Cancer
    Dan, L.
    Xia, Y.
    He, Y.
    Weimin, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [48] Validation of the Lung Immune Prognostic Index in patients with untreated advanced non-small cell lung cancer: Post hoc analysis of the IMpower 130, 131 and 150 trials
    Auclin, Edouard
    Dugage, Matthieu Roulleaux
    Gorria, Teresa
    Vauchier, Charles
    Thibault, Constance
    Laguna, Juan Carlos
    Lupinacci, Lorena
    Crous, Carme
    Naigeon, Marie
    Oudard, Stephane
    Besse, Benjamin
    Mezquita, Laura
    LUNG CANCER, 2025, 199
  • [49] Prognostic Value of the Lung Immune Prognostic Index for Metastatic Non-Small Cell Lung Cancer Patients: A Chinese Cohort Study
    Huang, Jing
    Pu, Hongjiang
    He, Jintao
    Tang, Xiaohu
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 881 - 893
  • [50] Clinical outcomes for immunotherapy beyond progression in patients with advanced non-small cell lung cancer
    Jia, Wenxiao
    Wang, Min
    Zhu, Hui
    Wu, Gang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)